Study to assess the effect of food and acid reducing agents on the absorption of Capivasertib in healthy participants

Trial Identifier: D3614C00005
Sponsor: AstraZeneca
Collaborator:
Parexel
NCTID:: NCT04944771
Start Date: July 2021
Primary Completion Date: May 2022
Study Completion Date: May 2022

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
German Translation

Trial Locations

Country Location
DE Berlin, DE, 14050
DE Hamburg, DE, 20251